{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:47:39Z","timestamp":1791308859425,"version":"4.3.1"},"reference-count":46,"publisher":"Public Library of Science (PLoS)","issue":"10","license":[{"start":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T00:00:00Z","timestamp":1286496000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0013245","type":"journal-article","created":{"date-parts":[[2010,10,8]],"date-time":"2010-10-08T18:59:12Z","timestamp":1286564352000},"page":"e13245","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Production and Characterisation of a Neutralising Chimeric Antibody against Botulinum Neurotoxin A"],"prefix":"10.1371","volume":"5","author":[{"given":"Julie","family":"Prigent","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Mazuet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Boquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Lamourette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Volland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel R.","family":"Popoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Cr\u00e9minon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phanie","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2010,10,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1128\/MMBR.46.1.86-94.1982","article-title":"Bacterial toxins: a table of lethal amounts.","volume":"46","author":"DM Gill","year":"1982","journal-title":"Microbiol Rev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"e1271","DOI":"10.1371\/journal.pone.0001271","article-title":"Analysis of the neurotoxin complex genes in Clostridium botulinum A1\u2013A4 and B1 strains: BoNT\/A3, \/Ba4 and \/B1 clusters are located within plasmids.","volume":"2","author":"TJ Smith","year":"2007","journal-title":"PLoS One"},{"key":"ref3","first-page":"1","article-title":"Ecology of neurotoxigenic strains of clostridia.","volume":"195","author":"MR Popoff","year":"1995","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism.","volume":"41","author":"J Sobel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1128\/IAI.64.5.1589-1594.1996","article-title":"Molecular composition of Clostridium botulinum type A progenitor toxins.","volume":"64","author":"K Inoue","year":"1996","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"4478","DOI":"10.1128\/AEM.71.8.4478-4486.2005","article-title":"Characterization of botulinum progenitor toxins by mass spectrometry.","volume":"71","author":"HB Hines","year":"2005","journal-title":"Appl Environ Microbiol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1128\/IAI.66.6.2420-2425.1998","article-title":"Biophysical characterization of the stability of the 150-kilodalton botulinum toxin, the nontoxic component, and the 900-kilodalton botulinum toxin complex species.","volume":"66","author":"F Chen","year":"1998","journal-title":"Infect Immun"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action.","volume":"44","author":"LL Simpson","year":"2004","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1113\/jphysiol.1949.sp004364","article-title":"The action of botulinum toxin on the neuro-muscular junction.","volume":"109","author":"AS BURGEN","year":"1949","journal-title":"J Physiol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1074\/jbc.M209821200","article-title":"Evaluation of the therapeutic usefulness of botulinum neurotoxin B, C1, E, and F compared with the long lasting type A. Basis for distinct durations of inhibition of exocytosis in central neurons.","volume":"278","author":"PG Foran","year":"2003","journal-title":"J Biol Chem"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management.","volume":"285","author":"SS Arnon","year":"2001","journal-title":"JAMA"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0168-6054(03)00114-4","article-title":"[Mode of action of botulinum neurotoxin: pathological, cellular and molecular aspect].","volume":"46","author":"B Poulain","year":"2003","journal-title":"Ann Readapt Med Phys"},{"key":"ref13","first-page":"1","article-title":"Biological and chemical terrorism: strategic plan for preparedness and response. Recommendations of the CDC Strategic Planning Workgroup.","volume":"49","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrmicro974","article-title":"Passive antibody therapy for infectious diseases.","volume":"2","author":"A Casadevall","year":"2004","journal-title":"Nat Rev Microbiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"833","DOI":"10.3201\/eid0808.010516","article-title":"Passive antibody administration (immediate immunity) as a specific defense against biological weapons.","volume":"8","author":"A Casadevall","year":"2002","journal-title":"Emerg Infect Dis"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiologic review.","volume":"129","author":"RL Shapiro","year":"1998","journal-title":"Ann Intern Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/DMP.0b013e318158c5fd","article-title":"Botulism: cause, effects, diagnosis, clinical and laboratory identification, and treatment modalities.","volume":"1","author":"ZF Dembek","year":"2007","journal-title":"Disaster Med Public Health Prep"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1542\/peds.2006-0646","article-title":"Creation and development of the public service orphan drug Human Botulism Immune Globulin.","volume":"119","author":"SS Arnon","year":"2007","journal-title":"Pediatrics"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type A foodborne botulism.","volume":"76","author":"CO Tacket","year":"1984","journal-title":"Am J Med"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/0002-9343(80)90469-6","article-title":"Hypersensitivity reactions associated with botulinal antitoxin.","volume":"69","author":"RE Black","year":"1980","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"5450","DOI":"10.1128\/IAI.73.9.5450-5457.2005","article-title":"Sequence variation within botulinum neurotoxin serotypes impacts antibody binding and neutralization.","volume":"73","author":"TJ Smith","year":"2005","journal-title":"Infect Immun"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"e3023","DOI":"10.1371\/journal.pone.0003023","article-title":"Neutralization of botulinum neurotoxin by a human monoclonal antibody specific for the catalytic light chain.","volume":"20;3","author":"SP Adekar","year":"2008","journal-title":"PLoS One"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jim.2008.03.003","article-title":"Development and partial characterization of high-affinity monoclonal antibodies for botulinum toxin type A and their use in analysis of milk by sandwich ELISA.","volume":"20;336","author":"LH Stanker","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.jim.2007.11.006","article-title":"A sensitive sandwich enzyme immunoassay for free or complexed Clostridium botulinum neurotoxin type A.","volume":"330","author":"H Volland","year":"2008","journal-title":"Journal of Immunological Methods"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.febslet.2004.06.094","article-title":"Interaction between the two subdomains of the C-terminal part of the botulinum neurotoxin A is essential for the generation of protective antibodies.","volume":"572","author":"M Tavallaie","year":"2004","journal-title":"FEBS Lett"},{"key":"ref26","article-title":"Characterisation of Botulinum Neurotoxin Type A Neutralizing Monoclonal Antibodies and Influence of Their Half-lives on Therapeutic Activity","author":"C Mazuet","year":"2010"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.pep.2004.06.022","article-title":"Production and purification of a chimeric monoclonal antibody against botulinum neurotoxin serotype A.","volume":"37","author":"MC Mowry","year":"2004","journal-title":"Protein Expr Purif"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0022-1759(00)00322-7","article-title":"Baculovirus expression cassette vectors for rapid production of complete human IgG from phage display selected antibody fragments.","volume":"247","author":"M Liang","year":"2001","journal-title":"J Immunol Methods"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","article-title":"Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E.","volume":"150","author":"CH Hatheway","year":"1984","journal-title":"J Infect Dis"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1016\/S0264-410X(00)00066-9","article-title":"A possible explanation for the discrepancy between ELISA and neutralising antibodies to tetanus toxin.","volume":"18","author":"J Dokmetjian","year":"2000","journal-title":"Vaccine"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt0602-597","article-title":"Protection against anthrax toxin by recombinant antibody fragments correlates with antigen affinity.","volume":"20","author":"JA Maynard","year":"2002","journal-title":"Nat Biotechnol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"11346","DOI":"10.1073\/pnas.172229899","article-title":"Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody.","volume":"%20;99","author":"A Nowakowski","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1128\/IAI.00405-09","article-title":"Antibody protection against botulinum neurotoxin intoxication in mice.","volume":"77","author":"LW Cheng","year":"2009","journal-title":"Infect Immun"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.jim.2008.01.015","article-title":"Hybridoma populations enriched for affinity-matured human IgGs yield high-affinity antibodies specific for botulinum neurotoxins.","volume":"%20;333","author":"SP Adekar","year":"2008","journal-title":"J Immunol Methods"},{"key":"ref35","article-title":"Botulinum antitoxin. 4th edition","year":"2002"},{"key":"ref36","first-page":"813","article-title":"A fluorometric method for the determination of hippuric acid.","volume":"57","author":"GL Ellman","year":"1961","journal-title":"J Lab Clin Med"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/276269a0","article-title":"A better cell line for making hybridomas secreting specific antibodies.","volume":"276","author":"M Shulman","year":"1978","journal-title":"Nature"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.4049\/jimmunol.131.5.2267","article-title":"Murine hybridomas secreting natural monoclonal antibodies reacting with self antigens.","volume":"131","author":"G Dighiero","year":"1983","journal-title":"J Immunol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0378-1119(89)90359-4","article-title":"Engineering hybrid genes without the use of restriction enzymes: gene splicing by overlap extension.","volume":"77","author":"RM Horton","year":"1989","journal-title":"Gene"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0022-1759(96)00208-6","article-title":"Reliable cloning of functional antibody variable domains from hybridomas and spleen cell repertoires employing a reengineered phage display system.","volume":"201","author":"A Krebber","year":"1997","journal-title":"J Immunol Methods"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/abio.2000.4711","article-title":"Quantitative measurement of bitagged recombinant proteins using an immunometric assay: application to an anti-substance P recombinant antibody.","volume":"284","author":"D Boquet","year":"2000","journal-title":"Anal Biochem"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1021\/bp960086t","article-title":"Optimization of an assay for baculovirus titer and design of regimens for the synchronous infection of insect cells.","volume":"13","author":"KU Dee","year":"1997","journal-title":"Biotechnol Prog"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jchromb.2006.09.030","article-title":"Protein A chromatography for antibody purification.","volume":"848","author":"S Hober","year":"2007","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/S0021-9258(19)75212-0","article-title":"Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.","volume":"252","author":"DW Cleveland","year":"1977","journal-title":"J Biol Chem"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ab.2003.12.025","article-title":"Characterizing high-affinity antigen\/antibody complexes by kinetic- and equilibrium-based methods.","volume":"328","author":"AW Drake","year":"2004","journal-title":"Anal Biochem"},{"key":"ref46","article-title":"Botulism in the United States 1899\u20131996","year":"1998"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0013245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T07:17:50Z","timestamp":1711869470000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0013245"}},"subtitle":[],"editor":[{"given":"Edgardo","family":"Moreno","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2010,10,8]]},"references-count":46,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2010,10,8]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0013245","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,10,8]]}}}